Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Utilities Select Sector SPDR Fund — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Utilities Select Sector SPDR Fund trades at $41.39 (market cap $23.60B). The key difference: Utilities Select Sector SPDR Fund is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Utilities Select Sector SPDR Fund for 80 Days on average.
| HALO | XLU | |
|---|---|---|
Market Cap | $12.58B | $23.60B |
Volume | 2,179,278 | 28,758,237 |
Sector | Health | — |
52-Week High | $115.22 | $47.73 |
52-Week Low | $61.63 | $39.25 |
Typical Hold Time | 1 Days | 80 Days |
Enterprise Value | $14.49B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLU trades at $41.07, down 0.19% on the day, as utility stocks face pressure from rising interest rates. The ETF recently hit 52-week lows amid sector-wide selling, though technical indicators show a mixed picture with bullish moving averages but neutral oscillators. Recent news highlights oversold conditions in utilities, with the sector experiencing its steepest monthly drop in nearly two years according to 24/7 Wall Street (2026-10-02).
The outlook remains challenged by interest rate sensitivity, but defensive characteristics could provide support if economic uncertainty persists. Key risks include continued rate hikes and regulatory headwinds, while potential catalysts include defensive rotation during market volatility and AI-driven power demand growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
